On Friday, Relmada Therapeutics Inc (NASDAQ: RLMD) opened lower -9.52% from the last session, before settling in for the closing price of $4.83. Price fluctuations for RLMD have ranged from $0.24 to $5.12 over the past 52 weeks.
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 0.68%. Company’s average yearly earnings per share was noted 63.40% at the time writing. With a float of $63.14 million, this company’s outstanding shares have now reached $73.33 million.
Relmada Therapeutics Inc (RLMD) Insider Updates
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Relmada Therapeutics Inc is 13.90%, while institutional ownership is 14.57%. The most recent insider transaction that took place on Dec 15 ’25, was worth 113,300. In this transaction Chief Executive Officer of this company bought 27,500 shares at a rate of $4.12, taking the stock ownership to the 1,300,000 shares. Before that another transaction happened on Dec 15 ’25, when Company’s Chief Financial Officer bought 11,665 for $4.12, making the entire transaction worth $48,060. This insider now owns 800,000 shares in total.
Relmada Therapeutics Inc (RLMD) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around 63.40% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 39.91% during the next five years compared to 0.68% growth over the previous five years of trading.
Relmada Therapeutics Inc (NASDAQ: RLMD) Trading Performance Indicators
Check out the current performance indicators for Relmada Therapeutics Inc (RLMD). In the past quarter, the stock posted a quick ratio of 2.86.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.80, a number that is poised to hit -0.16 in the next quarter and is forecasted to reach -0.54 in one year’s time.
Technical Analysis of Relmada Therapeutics Inc (RLMD)
As of the previous 9 days, the stock’s Stochastic %D was 74.59%.
During the past 100 days, Relmada Therapeutics Inc’s (RLMD) raw stochastic average was set at 83.57%, which indicates a significant increase from 38.62% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.39 in the past 14 days, which was higher than the 0.32 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $3.73, while its 200-day Moving Average is $1.57. Now, the first resistance to watch is $4.84. This is followed by the second major resistance level at $5.31. The third major resistance level sits at $5.63. If the price goes on to break the first support level at $4.05, it is likely to go to the next support level at $3.73. Assuming the price breaks the second support level, the third support level stands at $3.26.
Relmada Therapeutics Inc (NASDAQ: RLMD) Key Stats
There are currently 73,334K shares outstanding in the company with a market cap of 320.47 million. Presently, the company’s annual sales total 0 K according to its annual income of -79,980 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -10,090 K.
